Toggle Main Menu Toggle Search

Open Access padlockePrints

De novo and rare inherited mutations implicate the transcriptional coregulator TCF20/SPBP in autism spectrum disorder

Lookup NU author(s): Professor Jeremy Parr

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Background: Autism spectrum disorders (ASDs) are common and have a strong genetic basis, yet the cause of ~70-80% ASDs remains unknown. By clinical cytogenetic testing, we identified a family in which two brothers had ASD, mild intellectual disability and a chromosome 22 pericentric inversion, not detected in either parent, indicating de novo mutation with parental germinal mosaicism. We hypothesised that the rearrangement was causative of their ASD and localised the chromosome 22 breakpoints. Methods: The rearrangement was characterised using fluorescence in situ hybridisation, Southern blotting, inverse PCR and dideoxy-sequencing. Open reading frames and intron/exon boundaries of the two physically disrupted genes identified, TCF20 and TNRC6B, were sequenced in 342 families (260 multiplex and 82 simplex) ascertained by the International Molecular Genetic Study of Autism Consortium (IMGSAC). Results: IMGSAC family screening identified a de novo missense mutation of TCF20 in a single case and significant association of a different missense mutation of TCF20 with ASD in three further families. Through exome sequencing in another project, we independently identified a de novo frameshifting mutation of TCF20 in a woman with ASD and moderate intellectual disability. We did not identify a significant association of TNRC6B mutations with ASD. Conclusions: TCF20 encodes a transcriptional coregulator (also termed SPBP) that is structurally and functionally related to RAI1, the critical dosagesensitive protein implicated in the behavioural phenotypes of the Smith-Magenis and Potocki-Lupski 17p11.2 deletion/duplication syndromes, in which ASD is frequently diagnosed. This study provides the first evidence that mutations in TCF20 are also associated with ASD.


Publication metadata

Author(s): Babbs C, Lloyd D, Pagnamenta AT, Twigg SRF, Green J, McGowan SJ, Mirza G, Naples R, Sharma VP, Volpi EV, Buckle VJ, Wall SA, Knight SJL, Parr JR, Wilkie AOM

Publication type: Article

Publication status: Published

Journal: Journal of Medical Genetics

Year: 2014

Volume: 51

Issue: 11

Pages: 737-747

Print publication date: 01/11/2014

Online publication date: 14/10/2014

Acceptance date: 13/08/2014

Date deposited: 23/11/2017

ISSN (print): 0022-2593

ISSN (electronic): 1468-6244

Publisher: BMJ Publishing Group

URL: https://doi.org/10.1136/jmedgenet-2014-102582

DOI: 10.1136/jmedgenet-2014-102582

PubMed id: 25228304


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
090532/Z/09/Z
078666
093329
10-11/04

Share